Agrivalle Partners Ginkgo Bioworks To Advance Its Biological Products

RTTNews | 649天前
Agrivalle Partners Ginkgo Bioworks To Advance Its Biological Products

(RTTNews) - Brazilian agricultural biologicals company Agrivalle announced Friday a new partnership with Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity.

Together, the companies will collaborate on building cutting edge technologies to advance Agrivalle's biological products, including next-gen fertilizers and biocontrol agents.

Ginkgo is bringing its suite of advanced biology tools to the partnership with Agrivalle. Ginkgo will leverage its Strain Optimization Services to improve the efficacy of Agrivalle's biocontrol products.

In planned future projects, Ginkgo intends to work with Agrivalle to discover and optimize plant-compatible microbes that can provide crop nutrition, and to engineer organisms that can make compounds to specifically target certain pests.

read more
Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets

Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets

Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity, announced Thursday the acquisition of microbial innovation firm AgBiome, Inc.'s platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as AgBiome's development pipeline.
RTTNews | 524天前
Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges

Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges

Ahead of its presentation at the 42nd Annual J.P. Morgan Healthcare Conference later on Wednesday, Ginkgo Bioworks (DNA) said it expects to meet its previously disclosed new program and revenue guidance ranges in 2023, based on its preliminary unaudited estimates.
RTTNews | 616天前
Ginkgo Bioworks To Acquire Zymergen In All-stock Deal

Ginkgo Bioworks To Acquire Zymergen In All-stock Deal

Cell programming firm Ginkgo Bioworks Holdings, Inc. (DNA) and biotechnology company Zymergen, Inc. (ZY) announced Monday they have entered into a definitive agreement under which Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization.
RTTNews | 1150天前
Fed Cuts Rates By Quarter Point, Forecasts Two More Rate Cuts This Year

Fed Cuts Rates By Quarter Point, Forecasts Two More Rate Cuts This Year

In a widely expected move, the Federal Reserve on Wednesday announced that it has decided to lower interest rates by a quarter point, marking the first rate cut of 2025. The Fed said it decided to lower the target range for the federal funds rate by 25 basis points to 4.0 percent to 4.25 percent, citing a shift in the balance of risks.
RTTNews | 1小时45分钟前
Swiss Market Ends Marginally Down

Swiss Market Ends Marginally Down

After a weak start and a subsequent long spell in negative territory, the Switzerland market briefly moved above the flat line in late afternoon trade on Wednesday, but failed to sustain momentum and settled marginally down with a few frontline stocks turning weak again.
RTTNews | 2小时12分钟前